股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2026年2月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 15, ...

上市公司：钱江摩托（000913），信隆健康（002105），征和工业（003033），久祺股份（300994）， 林海股份（600099），上海凤凰（600679），中路股份（600818），力帆科技（601777），春风动力 （603129），爱玛科技（603529），隆鑫通用（603766），永安行（603776），新日股份（603787）， 绿通科技（301322），涛涛车业（301345），华洋赛车（834058） 相关报告：智研咨询发布的《2026-2032年中国摩托车行业市场全景评估及发展策略分析报告》 根据中国汽车工业(摩托车)产销快讯数据显示：2025年12月江苏创新摩托车制造有限公司摩托车产量为 4000辆，同比下降6.98%，销量为3960辆，同比下降18.16%，产销率为99%，积压40辆；2025年1-12月 江苏创新摩托车制造有限公司摩托车产量为28850辆，产量累计同比下滑15.27%，2025年1-12月江苏创 新摩托车制造有限公司销量为28231辆，销量累计同比下滑9.63%。 近一年江苏创新摩托车制造有限公司摩托车产销情况统计图 数据来源：中国汽车工业(摩托车)产销快讯，智 ...

中国—中亚经贸合作再攀新高，商务部最新数据显示，2025年中国—中亚货物贸易进出口总额达 1063亿美元，同比增长12%，增速较上年提升6个百分点。在这股强劲的合作浪潮中，江苏以务实举措 推动中亚好物走进国内市场，更以创新平台搭建起双向奔赴的贸易"金桥"。 自2025年6月"中国—中亚贸易畅通合作平台"在南京揭牌成立以来，已有20多家中亚机构相继入 驻。该平台不仅成为对接中亚市场的"一站式会客厅"，更成为链接进口商、物流商和多种服务的"超级 路由器"，让江苏与中亚的贸易合作从美好蓝图走向具象实践。 "一站式"服务，凸显桥梁纽带作用 走进位于南京市玄武区的中国—中亚贸易畅通合作平台展示区，哈萨克斯坦驼奶粉、吉尔吉斯斯坦 蜂蜜、乌兹别克斯坦蚕丝等中亚特色产品整齐陈列。依托这一平台，大批中亚优质农产品加速进入中国 市场。 "我们收集哈萨克斯坦数百家企业的销售需求，通过平台定向对接国内渠道，让优质农产品精准触 达中国消费者。"平台运营方苏豪亚欧互联科技（南京）有限公司负责人顾南燕介绍，目前通过平台链 接的中哈农产品、矿产品及二手车等进出口贸易意向订单规模已达数亿美元。 依托线上线下双阵地，平台的桥梁纽带作用持续凸显。 ...

Core Viewpoint - As of January 15, a total of 105 stocks reached their 52-week highs, with notable performers including 德莱建业 (01546), 东曜药业－Ｂ (01875), and 大森控股 (01580) achieving high rates of 78.00%, 51.36%, and 37.61% respectively [1]. Summary by Category 52-Week Highs - 德莱建业 (01546) closed at 0.355, with a peak of 0.445, marking a high rate of 78.00% [1]. - 东曜药业－Ｂ (01875) closed at 4.190, reaching a high of 4.450, with a high rate of 51.36% [1]. - 大森控股 (01580) closed at 0.275, with a peak of 0.300, achieving a high rate of 37.61% [1]. - 顺兴集团控股 (01637) and 怡园酒业 (08146) also showed significant increases, with high rates of 36.36% and 24.74% respectively [1]. Additional Notable Stocks - JBB BUILDERS (01903) reached a high rate of 24.12% with a closing price of 2.830 [1]. - 天臣控股 (01201) and 江苏创新 (02116) had high rates of 15.38% and 15.00% respectively [1]. - 万国黄金集团 (03939) and 竣球控股 (01481) also performed well, with high rates of 12.95% and 12.44% respectively [1]. 52-Week Lows - The report also noted stocks reaching 52-week lows, with 天彩控股 (03882) showing a low rate of -14.42% [3]. - 中国智慧能源 (01004) and 基石控股 (01592) followed with low rates of -13.64% and -12.86% respectively [3]. - 弘毅文化集团－旧 (02990) and 中原建业 (09982) also reported significant declines of -9.09% and -6.06% respectively [3].

上市公司：钱江摩托（000913），信隆健康（002105），征和工业（003033），久祺股份（300994）， 林海股份（600099），上海凤凰（600679），中路股份（600818），力帆科技（601777），春风动力 （603129），爱玛科技（603529），隆鑫通用（603766），永安行（603776），新日股份（603787）， 绿通科技（301322），涛涛车业（301345），华洋赛车（834058） 数据来源：中国汽车工业(摩托车)产销快讯，智研咨询整理 相关报告：智研咨询发布的《2026-2032年中国摩托车行业市场全景评估及发展策略分析报告》 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 根据中国汽车工业(摩托车)产销快讯数据显示：2025年11月江苏创新摩托车制造有限公司摩托车产量为 2700辆，同比下降43.16%，销量为2371辆，同比下降40.08%，产销率为87. ...

Core Viewpoint - The "Talent Night Market" initiative in Jiangsu province aims to provide innovative employment opportunities by extending job services to nighttime, addressing the mismatch in availability between job seekers and employers [1][2]. Group 1: Event Overview - The first event of the "Talent Night Market" was held in Nanjing, featuring over 50 employers offering 2,300 job positions across various sectors including software, smart manufacturing, and hospitality [1]. - The initiative is part of a broader campaign titled "Night Market Assists Beautiful Future," which will host over 350 events across the province in January and February [1]. Group 2: Job Categories - Job openings are categorized into three main types: 1. High-end technical positions in technology innovation, with salaries exceeding 10,000 yuan per month and annual salaries up to 450,000 yuan, targeting recent graduates and experienced professionals [2]. 2. Steady employment positions in manufacturing, aimed at ensuring continuous production during the Spring Festival [2]. 3. Flexible service roles in modern service industries, providing opportunities for job seekers facing employment difficulties [2]. Group 3: Additional Services - The human resources department plans to release a monthly activity calendar, leveraging major events to attract job seekers and provide comprehensive employment services [3]. - A "Skills Night School" will be established to enhance workers' skills, focusing on digital professions, AI, and traditional crafts, with a target of opening at least 300 training points and training over 60,000 individuals throughout the year [3].

Core Insights - Jiangsu Province has released its first batch of innovative drug and medical device products, including 149 products, with Suzhou contributing 60, accounting for 40% of the total [1] - Suzhou's selected products cover four key areas: Class 1 innovative drugs, Class 2 improved new drugs, Class 3 innovative medical devices, and Class 2 innovative medical devices, forming a comprehensive innovation product matrix [1] Group 1: Innovative Drugs - Suzhou has 14 Class 1 innovative drugs, addressing various treatment areas such as oncology, autoimmune diseases, metabolism, and infections [1] - Among these, Innovent Biologics' Ma Shidu Peptide Injection is the world's first dual receptor agonist for glucagon and GLP-1, targeting obesity-related metabolic issues [1] - Suzhou also includes 6 Class 2 improved new drugs, with BeiGene's Zebrutinib being the first domestically developed cancer drug approved in the U.S., projected to achieve global sales of 12.527 billion yuan in the first half of 2025, a 56.2% year-on-year increase [1] Group 2: Innovative Medical Devices - Suzhou has 25 Class 3 innovative medical devices and 15 Class 2 innovative medical devices, representing 69% and 43% of the provincial totals, respectively [1] - Peijia Medical's transcatheter aortic valve system offers a minimally invasive treatment option for heart valve disease, showcasing domestic technological advancements [2] - The implantable left ventricular assist device by Tongxin Medical is the first fully magnetic levitation artificial heart product approved in China, providing new hope for end-stage heart failure patients [2] Group 3: Industry Development and Support - Suzhou has over 4,200 biopharmaceutical companies, with an expected output value exceeding 250 billion yuan by 2025, supported by a complete industrial chain from early research to commercialization [2] - The local government is focusing on nurturing biopharmaceutical enterprises and enhancing policy support to promote the industrialization and clinical application of innovative results [2][3] - Market regulatory departments have implemented various service measures to accelerate the development and market entry of innovative products, including establishing a specialized review and approval service team [3][4]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2026年1月7日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 15 ...

Group 1 - The core viewpoint of the article highlights the significant decline in motorcycle production and sales for Jiangsu Innovation Motorcycle Manufacturing Co., Ltd. in October 2025, with production down by 70.07% and sales down by 57.04% year-on-year [1] - The production volume for October 2025 was reported at 2,200 units, while the sales volume was 2,133 units, resulting in a production-sales rate of 96.95% and an inventory of 67 units [1] - The data is sourced from the China Automotive Industry (Motorcycle) Production and Sales Quick Report, compiled by Zhiyan Consulting, a leading industry consulting firm in China [1] Group 2 - The article references various listed companies in the motorcycle industry, including Qianjiang Motorcycle, Xinlong Health, Zhenghe Industrial, and others, indicating a broad market context [1] - Zhiyan Consulting has released a comprehensive report titled "2026-2032 China Motorcycle Industry Market Panorama Assessment and Development Strategy Analysis Report," which may provide further insights into industry trends and forecasts [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 1 ...